Immunogold electron microscopy was used to ana lyze and quantify the Glutl glucose transporter in brain tissue from five patients undergoing surgery for treatment of seizures. Samples were prepared from two different regions of each re section: (I) the most actively spiking epileptogenic site, and (2) the least actively spiking region, as indicated by intraoperative EEG monitoring. Two configurations of endothelial cell Glutl were observed. About one half of the capillary profiles exam ined displayed abundant Glutl immunoreactivity on both lu minal and abluminal endothelial membranes. In the remainder of the profiles, reduced Glutl labeling was seen, but adjacent erythrocyte membranes remained highly Glutl immunoreac
transporter activity in the blood-brain barrier was characterized by a bimodal Glutl distribution in which the smaller (type B) endothelial cells displayed low Glutl immunoreactivity, whereas adjacent (and even contiguous) larger (type A) endo thelial cells showed 5-to lO-fold greater expression of mem brane Glut! transporter protein. Because this transporter facili tates glucose entry to the brain, small pericapillary volumes of brain tissue may have quite different concentrations of glucose.
We hypothesize that in complex partial seizures and other forms of brain insult, an alteration of blood-brain barrier Glutl glucose transporter activity is indicated by the appearance of these two subpopulations of endothelial cells. In comparison with previous studies of human brain capillaries in hemangio blastoma and brain injury, endothelial Glutl density was ap parently reduced (interictally) in atIected temporal lobes of patients with complex partial seizures. Key Words: Abluminal and luminal membrane Glutl-Capillary size alterations Glial fibrillary acidic protein-Human blood-brain barrier, glucose transporter-Human serum albumin-Quantitative im munogold electron microscopy-Seizures, temporal lobe.
upregulated as a result of the seizure activity. This con clusion is supported by observations that in vivo mea surements of cerebral glucose utilization rates (in animal seizure models) exceed the BBB glucose transporter maximal velocity in normally fed rats (Pardridge, 1983) . Presumably after seizure activity has subsided, and glu cose utilization rates normalize (Duncan, 1992) , glucose transporter activity undergoes a postictal downregula tion. As the Glutl isoform is the principal glucose trans porter in the BBB (Boado and Pardridge, 1990; Par dridge et aI., 1990) , intracellular localization of trans porter in brain capillaries can be both visualized and quantitatively measured using electron microscopic im munogold methods (Cornford et aI., 1994 (Cornford et aI., , 1995 (Cornford et aI., , 1996 .
To complement dynamic positron emission tomo graphic scan analyses (Cornford et al., in preparation) , additional information about the BBB glucose trans porter was sought through examination of tissues re sected from patients undergoing surgical treatment for their seizure disorders. Antisera have been prepared that can specifically immunolocalize the Glutl glucose trans porter protein. The Glut! transporter protein represents 5% of the total human erythrocyte membrane protein, by far the highest concentration density for any glucose transporter (Mueckler, 1994) , affording an excellent in ternal control for antigen localization methods in brain tissue. However, recent electron microscopic immuno gold analyses of Glut! immunoreactivity in human brain resections from a variety of clinical situations have con sistently demonstrated greater Glut! densities on the brain capillary endothelial membranes than on the eryth rocyte membranes seen within the capillary lumens (Cornford et al., 1994 (Cornford et al., , 1995 (Cornford et al., , 1996 . Therefore, the great est concentration density for any glucose transporter may now be reassigned to the so-called gatekeeper of the brain (Pardridge 1987) , the BBB endothelial cell mem branes.
Given this abundance of Glutl activity in human brain endothelial cells, it seemed likely that physiologic alter ations of transporter activity in conditions such as sei zures should be both detectable and quantifiable. In the present study, we examined BBB Glut! distribution pat terns to test the hypothesis that altered immunoreactive Glutl transporter density could be demonstrated interic tally in temporal lobe resections, including the seizure focus from patients with complex partial seizures.
METHODS
Prior approval for this investigation was obtained from the appropriate institutional human studies review boards. Brain tissue specimens from the affected temporal lobe were obtained from five hospitalized patients with a history of complex partial seizures, unresponsive to conventional anticonvulsant drug treatments, who underwent surgical treatment. In addition, in traoperative EEG monitoring was performed, and the identities of the regions of highest spiking activity and of the resected area with least active spiking activity were sampled for com parative analytical purposes. In our experience, freshly fixed material is of paramount importance for studies of human BBB electron microscopy and Glutl-immunogold localization (Cornford et aI., 1995) .
Resected samples designated case 1 came from a 42-year-old man with idiopathic onset of progressively escalating seizures 3 years before resection, who was subsequently diagnosed with Herpes II encephalitis. Case 2 was a 29-year-old man with a history of childhood spinal meningitis and seizure onset at age 21. A left temporal lobectomy had been performed 4 months earlier, and the tissues examined came from a second surgery in which a left inferior frontal resection was performed to treat recurring seizures. Case 3 tissues came from a 41-year-old man with a history of seizures beginning at age 2; anticonvulsant drug treatments controlled his seizures until he suffered a trau matic injury with loss of consciousness in an automobile acci-dent 6 years before surgical intervention. Case 4 was a 35-year old man with a history of unprovoked seizures beginning at 9 years of age; a left anterior temporal lobectomy had been per formed 9 months before this second resection of the region close to the left inferior frontal gyrus. Case 5 was a 38-year-old man with a 13-year history of seizures subsequent to a trau matic head injury who underwent a right temporal lobe resec tion.
Small blocks of resected brain tissue from regions identified as having the most and least active spiking activity were ob tained as soon as possible from the operating room and were fixed by immersion as described by Farrell and Pardridge (1991) for Glut! immunogold electron microscopy. As de scribed below, the concomitant demonstration (in the same sections) of erythrocyte Glutl transporter was used as an indi cator of appropriate tissue preparation.
The ice-cold fixative contained 2% paraformaldehyde in 0.05% glutaraldehyde, 0.9% NaCI, and 0.15 mg/mL CaCl2 in 0.01 mollL sodium phosphate buffer, pH 7.4. The tissues were further dissected into small (1 mm3) cubes and were allowed to fix for a total of 0.5 to 1.5 hours, after which the fixative was removed and replaced with Sorensen's buffer (0.1 mollL phos phate buffer, pH 7.4) and left overnight at 4°C. They were then dehydrated and embedded in LR-white resin (Farrell and Par dridge, 1991) . Because of the variable time periods of inter ruption in the circulation to the resected tissue, and delays in immersing these tissues in fixative, tissue samples were rou tinely subjected to a preliminary examination of Glutl epitope viability. Only brain tissue samples in which intravascular erythrocyte membranes were Glut! positive were selected for further quantitative examination (five cases). If Glutl immu noreactivity was reduced on erythrocyte membranes in either of the paired samples, tissues were judged to be inadequate or improperly fixed for Glutl-immunogold electron microscopy, and excluded (about 10 other samples) from further examina tion.
Antiserum preparation
A rabbit polyclonal antiserum to the purified human eryth rocyte Glut! glucose transporter (hGT), a 492-amino acid pep tide (Meuckler, 1990) , was prepared as described previously (Pardridge et aI., 1990) . For immunogold staining, the anti-hGT antiserum and the preimmune serum were both used at a dilu tion of 1 :800. The antigen used to prepare this antisera was hGT, purified from freshly isolated human red cells using the method of Baldwin and Lienhard (1989) . The immunoreactiv ity of the antiserum has been confirmed in both Western blot analyses of isolated brain capillaries and immunocytochemical procedures. Absorption of the antiserum with hGT eliminated antiserum reactivity with brain microvessels (Pardridge et aI., 1990) . The human gene encoding the transporter is referred to as GLUTl, and throughout this manuscript is distinguished from the corresponding protein using lower case type, Glutl, as proposed by Meuckler (1990) .
Immunogold staining
The antisera against hGT (polyclonal), glial fibrillary acidic protein (GFAP, polyclonal bovine and monoclonal human; DAKO Corp., Carpenteria, CA, U.S.A.), and human serum albumin (HSA) (polyclonal, DAKO Corp.) were used at con centrations of 1:800, 1:1,000, 1:400, and 1:2,000, respectively (overnight at 4°C). The secondary gold-labeled goat anti-rabbit or anti-mouse sera were used at 1 :60 to I: 100 for 2 hours at room temperature (22°C). For double staining, sections were simultaneously exposed' to polyclonal anti-hGT and mouse monoclonal GFAP antisera overnight (at 4°C). After complet-28 E. M. CORNFORD ET AL.
ing the wash procedure, these grids were exposed to a mixture of 10-nm-gold-conjugated goat anti-rabbit (Amersham, Ar lington Heights, fL, U.S.A.) and 20-nm-gold-conjugated goat anti-mouse serum (Ted Pella Inc., Redding, CA, U.S.A.). They were then fixed and stained as described previously (Farrell and Pardridge, 1991) . Blocks of the plastic-embedded resected tis sue were sectioned and stained for electron microscopic exami nation, and separate ultrathin sections were stained in parallel with control preimmune, normal rabbit and mouse IgG 1 sera.
Electron micrographs were taken with a JEOL electron micro scope at 80 kV.
Gold particles were counted on an average of 15 or more capillary profiles from each of the two brain tissue regions, and membrane density of immunoreactive Glut1 epitopes was de termined using a Sigma Scan image analysis system (Jandel Corp., Corte Madera, CA, U.S.A.). As in prior studies (Corn ford et aI., 1995 (Corn ford et aI., , 1996 , every available circular profile on each stained grid was imaged for analysis to obtain a fully repre sentative sample of capillary Glut1 density patterns. A descrip tion of the digital analyses and quantification of capillary pro files appears elsewhere (Cornford et aI., 1993) .
All data are presented in the form of a mean ± SD. Capillary profiles containing approximately 360 or greater total Glut1 immunogold particles and more than 10 Glut1 immunogold particles per micrometer on the luminal membrane circumfer ence were categorized as type A profiles; all uniformly stained profiles with fewer gold particles were type B profiles. Re 
RESULTS
In the human brain resections examined in the present study, capillary profiles were observed to be variably immunoreactive to the Glutl glucose transporter. A bi modal distribution of glucose transporter immunoreac tivity was observed in endothelia; individual cells were either highly immunoreactive (type A, 10 to 50 gold particles per micrometer of membrane) or weakly Glutl positive (type B, less than five particles per micrometer of membrane). The circular capillary profiles examined from interictal seizure resections exhibited one of three specific Glutl distribution patterns, differentiated by the following characteristics: 1. A Profiles: Entirely reactive endothelial capillaries ( Fig. 1 ). This capillary profile displays abundant Glutl glucose transporter immunoreactivity throughout the en tire capillary circumferences on both luminal and ablu minal membranes. Although the number of immunore active Glutl epitopes per micrometer of capillary mem brane was abundantly similar on both luminal and abluminal membranes, digital analyses (Table 1) had 0 to 2 interendothelial junctions (l or 2 type A en dothelial cells).
2. AB Profiles: Mixed-reactivity capillaries (Fig. 2) , displaying both type A and type B endothelial cells. This type of capillary profile displayed abundant Glut! trans porter activity on luminal and abluminal membranes, re stricted to a sector of the profile and adjacent to a uni formly low-reactivity sector. Thus these capillary pro files comprised two (or more) contiguous endothelial cells, one of which is highly immunoreactive type A and another that is type B, with low Glutl reactivity. The bimodal distribution of endothelial Glut 1 reactivity is readily apparent in these profiles. In the highly reactive sector (Fig. 2 , left side), the type A endothelial cell dis plays the characteristic slightly higher Glut ! density on the luminal membrane. In contrast, the type B endothe lial cell making up the low-reactive sector (Fig. 2 , right side) is further distinguished by lower Glut! immunore activity on the luminal than abluminal membrane.
3. B Profiles: Low-reactivity endothelial capillaries ( Fig. 3) , with all type B endothelial cells. The third type of capillary profile observed is remarkable for the low number of Glutl epitopes (Fig. 3, arrows) , averaging less than five gold particles per micrometer of membrane, demonstrable over all endothelial cells contributing to the entire capillary circumferences. Digital analyses (Table 2 ) typically indicate fewer Glut! epitopes on the luminal than abluminal membrane (i.e., a luminal to ab luminal ratio of approximately 1.0). The fact that eryth rocytes seen in the lumen of this type of capillary show a normal level of Glutl immunoreactivity on the red cell membrane indicates that the lack of endothelial labeling is not an artifact of poor tissue preservation or improper fixation.
As indicated in Fig. 4 , in the five different seizure resections examined, only about one half of the capillary profiles were type A (entirely Glutl reactive), and 10% to 35 % were type B, displaying little Glutl reactivity. In contrast, previous immunogold examinations of Glutl reactivity in human brain capillary profiles indicated 88% (in brain injury) to 100% (in hemangioblastoma capillaries) were the uniformly high-reactivity, type A capillary profiles, and no type B profiles were sampled from the tissues examined in the two prior studies (Com ford et aI., 1994 (Com ford et aI., , 1995 .
Digital analyses of type A reactive endothelial profiles (Table I ) from the seizure resections quantified the dra matic reduction in Glut! epitopes characterizing type B reactive endothelial cells (Table 2 ). In nominally reactive type B endothelial cells we observed an average of one to three Glut ! epitopes per micrometer of endothelial mem brane, whereas 10 to 30 Glutl epitopes per micrometer of endothelial membrane were seen in (highly reactive) type A endothelial cells ( Fig. 5 ).
FIG. 1. The typical appearance of an entirely reactive type A capillary profile double stained with 10-nm-immunogold-Glut1 and 20-nm immunogold-Iabeled GFAP (glial fibrillary acidic protein) from the less actively spiking area of a temporal lobe seizure resection. Note that the Glut1 glucose transporter immunogold epitopes can be seen around the entire capillary circumference. The Glut1 glucose transporter protein is abundant on both luminal and abluminal endothelial membranes, and also at the interendothelial cleft. Only a few GFAP epitopes (20-nm gold particles) are apparent. Scale bar = 0.5 (..1 m.
Interestingly, type A capillaries are also larger in di ameter, and more robust, than type B endothelial pro files. Morphometric variables, such as the endothelial cell membrane lengths and cytoplasmic areas, are greater in the type A than type B endothelia (Table 3) Luminal and abluminal membrane circumferences are reduced by 20% to 25% in type B endothelial capillaries (Table 3) .
EEG-based comparisons
Comparisons of the tissue samples taken from the more actively spiking and less actively spiking regions of the resection were undertaken to determine whether there were any detectable seizure-induced differences in cap illary types. The percentages of A, AB, and B profiles were similar in samples from the more actively spiking and less actively spiking resected regions ( Fig. 5 ). Digi tal analyses (Tables 1 and 2) revealed no significant dif ferences in capillary morphology or Glutl immunoreac tivity in comparisons of the electroencephalographically more actively spiking and less actively spiking tissue samples. Mean luminal and abluminal membrane cir cumferences, cytoplasmic volumes (areas), and vacuolar areas were all larger in the more actively spiking tissues (Table 3 ). In one patient, both gray and white matter from more and less actively spiking regions were sampled: proportions of type A and type B capillaries were similar (data not shown).
Distributions of HSA epitopes were examined as an indicator of in vivo BBB integrity in the resected tissues. Capillary profiles in which HSA was retained only inside the vascular lumen, with minimal penetration into the extravascular regions ( Fig. 6) , were presumed to repre sent the normal condition. When BBB integrity was compromised, the basal lamina appeared to retain some of the immunoreactive HSA in moderate extravasation (Fig. 7) . In more severe loss of barrier function, extrav-asation of HSA into the capillary endothelial cell, basal lamina, and neuropil was observed ( Fig. 8 ). In one re section in which digitally analyzed comparisons of the density of HSA (gold particles per f-Lm 2 ) in the capillary cell, the pericyte-basal lamina, and neuropil were per formed, we observed proportionally more extravasation in the more actively spiking regions of the resection than in the less actively spiking areas ( Fig. 9 ). Thus, as an ticipated, BBB integrity was compromised to a greater degree in the region characterized from intraoperative EEG as more actively spiking.
Analyses of GFAP density in the neuropil surrounding the capillaries provided an index of the relative degree of gliosis. Figure 10 shows that in two digitally quantified FIG. 2. The characteristic appearance of a type AB capillary profile double stained with 10-nm-immunogold-Glut1 and 20-nm immunogold-Iabeled GFAP from the more actively spiking region of a temporal lobe resection. This capillary profile demonstrates that in contiguous endothelial cells (separated by an intercellular cleft), Glut1 glucose transporter immunoreactivity can vary between two extremes; abundant and minimal. Note that the Glut1 glucose transporter epitopes are abundant on only a sector of the capillary circumference, comprising the type A endothelial cell on the left side of the profile (and the interendothelial clefts at the 6and 12-0'clock positions). The remainder of the sector (formed from an adjacent, contiguous type B endothelial cell) shows only a very few Glut1 glucose transporter epitopes, and relatively more on the abluminal than luminal membrane. Scale bar = 0.5 j.Jm. specimens, GFAP-immunogold densities were higher in the neuropil from the more actively spiking regions of the resections than in the less actively spiking areas.
DISCUSSION

Glut! glucose transporter activity in normal brain
It is noteworthy that lower total capillary Glut! and the lowest number of cytoplasmic and membrane associated Glutl epitopes were seen in case 4, and the highest in case 2. Because these tissues came from the inferior frontal lobe, and other tissues were from the temporal lobes, it seems possible that regional differ ences in capillary Glut! density may be found in thehu man brain. There has been no measurement of Glutl 1.55 ± 0.31 1.76 ± 0.82 1.3 ± 0.4 9.9 ± 8.9 8.6 ± 5.7 1.8 ± 0.7 0.9 ± 0.3 1.5 ± 1.5 immunogold density in normal human brain capillaries; postmortem or routine formalin-fixed surgical pathology tissue is not satisfactory for immunogold analyses, and although surgical resections would be most informative, normal brain tissue is not available. One line of evidence from cytochalasin B-binding studies suggests that the type B endothelial cells (Fig. 3) represent the normal condition. Such a conclusion is supported by the follow ing three observations. (1) The density of immunogold seen on these human BBB membranes (one to two gold particles per micrometer of membrane) is similar to that seen in the normal rat (Farrell and Pardridge, 199 1) and normal rabbit (Cornford et aI., 1993) brain capillaries.
(2) Cytochalasin B-binding studies of isolated brain mi crovessels indicate that glucose transporter density is FIG. 3. The typical appearance of a type S, minimally reactive capillary profile, double stained with 10-nm-immunogold-Glut1 and 20-nm-immunogold-labeled GFAP. This capillary is from the more actively spiking region of the resection, and many GFAP-positive fibrils can be seen outside the capillary basal lamina. Note the low Glut1-immunogold density (arrows) throughout the capillary profile, suggesting downregulation of Glut1 glucose transporter activity in all of the endothelial cells that contribute to this profile. Within the capillary lumen, high Glut1 immunoreactivity is seen on the erythrocyte membrane; this serves as a positive control and suggests that the loss of Glut1 from endothelial membranes is a biologically induced phenomenon, and not an artifact of tissue preparation or staining. Scale bar = 0.5 !-1m. similar (60 to 110 pmol/mg protein) in the rat (Dick et aI., 1984) , rabbit (Dwyer and Pardridge, 1993) , and hu man (Dick and Harik, 1986 ) BBB.
(3) Cytochalasin B binding studies suggest glucose transporter density is 10fold greater in human erythrocytes (Sogin and Hinkle, 1980) than in human BBB microvessels (Dick and Harik, 1986 ). In the present study the density of Glut l trans porter epitopes on erythrocyte membranes is three-to fivefold greater than on the luminal and abluminal mem branes of type B capillaries (Table 3) , approximating the expected "normal" distribution, but it is two-to three fold less than on the type A capillaries; therefore, there is a comparative lO-fold increase in BBB Glut l transporter on type A capillaries over "normal type B capillaries" within the seizure focus. Other observations, however, suggest that the type B nominally reactive endothelial cells (Fig. 3) represent a downregulated state of human Glut l glucose transporter activity in the BBB. For example, the epileptogenic fo cus in 70% to 80% of complex partial seizure patients is coincidentally identified interictally as a zone of hypo metabolism in fluorodeoxyglucose positron emission to mographic studies (Theodore et aI., 1983; Abou-Khalil et aI., 1987) ; consequently, elevated glucose transporter ac tivity, especially approximately lO -fold increases, would be somewhat paradoxical in temporal lobe epilepsy re sections.
Averaged from samples from the more actively and less actively spiking regions in the five cases examined, 50% ± 7% of the total capillary profiles are comprised wholly of type A endothelia, 26% ± 8% are type AB, and 23% ± 11% are type B (Fig. 4) ; in all five patients this pattern was similar. If Glut I density in type A endothelia are representative of the normal glucose transport and metabolic rate (designated as 100%), then profiles made of type B endothelia would represent 10% of the normal rate based on luminal membrane Glut l density, or a 90% reduction. Thus averaged over the epileptogenic focus, and based on the relative frequencies of type B endothe lia in AB profiles (26%) and B profiles (23%), the pre dicted reduction in metabolic rate would be approxi mately 30%. This value is not inconsistent with an ob served 26% ± 10% reduction in glucose utilization rates in the anatomic lesion (in localization-related epilepsy), as compared with the homologous contralateral brain re gion.
In brain injury, light microscope Glut l immunocyto chemistry on formalin-fixed, paraffin-embedded tissue from surgical debridement shows capillary profiles of alternating high and low reactivity, surrounding areas of red blood cell extravasation. The capillaries that corre spond to highly reactive type A endothelial cells in elec tron microscopic study appear as Glutl-positive capillar ies with immunocytochemistry, whereas Glutl-negative J Cereb Blood Flow Metab, Vol. 18, No. I, 1998 microvessels are composed of apparently type B endo thelial cells (Cornford et aI., 1996) . Also, in tumors such as glioblastoma multiforme (GBM), there is a loss of immunoreactive Glut l transporter (Guerin et aI., 1990; Harik and Roessmann 199 1; Nagamatsu et aI., 1993) , and immunocytochemistry indicates up to 80% of the capillary Glutl is lost (Guerin et aI., 1992) . It would be interesting to determine whether, in GBM cases, the pre dominant type of capillary profile is of low Glut! reac tivity, or type B.
Bimodal capillary Glutl density
The present study confirms that in the human brain two configurations of endothelial cells, exhibiting dra matically different Glutl glucose transporter densities, may characterize certain disease conditions. This bimo dal Glutl distribution is seen interictally, in the epilep togenic focus of patients with complex partial seizures ( Figs. 1-3) . Although a slightly different bimodal Glut l distribution has been observed in the retinal vasculature of the diabetic eye (Kumagai et aI., 1996) , the same two configurations of Glut l-reactive endothelia have been reported in debrided fragments from human brain injury (Cornford et aI., 1996) . Thus, the appearance of two endothelial cell configurations may represent a response pathway common to different forms of brain insult. Re cent studies also provide evidence that the Glutl glucose transporter belongs to the glucose-regulated protein fam ily of stress-inducible proteins (Wertheimer et aI., 199 1) , so it is not unexpected that pathophysiologic modula tions in BBB Glut l activity are seen. The unexplained (at present) aspect of this observation focuses on why two adjacent and contiguous endothelial cells, presumably exposed to the same stresses and signal transduction in puts, should exhibit divergent (mosaic) expression of the Glut l protein.
With respect to BBB capillary biology, it is notewor thy that the observed functional changes in capillaries, as suggested by the Glutl densities of type A and type B endothelia, are accompanied by concomitant changes in capillary morphology (Table 3) . Type A capillaries are significantly larger and more robust than the low-Glut 1reactive type B vessels, an observation that is not incon sistent with a previous report that proposed that changes in capillary circumference and cross-sectional areas oc curred in temporal lobe epilepsy brain microvasculature (Liwnicz et aI., 1990) . Digital analyses of capillaries (av eraged for the five patients examined) surprisingly indi cated that morphometric factors (luminal and abluminal membrane circumferences and cytoplasmic areas) were increased in type A endothelia as compared with type B capillaries. Type A capillaries would seem to be more important in transport phenomena, and perhaps are sub jected to greater pressures, more stretching, and greater Hemangioblastoma (Cornford et aI., (1995) and brain injury (Cornford et aI., 1996) data are included for comparison. * Significant differences, Type B versus Type A Profiles (P-values are listed in Column 2). No differences were detected in comparisons of more actively and less actively spiking tissues, for any of the parameters listed. stress than the smaller type B endothelia. In addition, our brain sampling was assisted with intraoperative electro encephalography to identify the most abnormal and least abnormal tissues resected. No differences in the distri bution of type A and type B endothelial cells, nor their respective morphometric variables, were seen in regions characterized by a greater or lesser temporal spiking ac tivity. Consequently, we presume that the two configu rations of Glut1 distribution observed characterize the entire epileptogenic resection. This is consistent with fluorodeoxyglucose positron emission tomographic find ings, which show that areas of altered metabolism in focal epilepsies include and extend beyond the anatomic lesion. (Because no en bloc temporal lobe resections were performed in this study, no near-normal surround tissue was examined.)
Significance of the two different
Glutl-distribution-related capillary configurations
The observation of bimodal Glutl densities has sig nificant implications for brain function, suggesting that some cylindrical pericapillary brain tissue regions in the human temporal lobe are supplied with approximately lO -fold more glucose than pericapillary brain tissues in an immediately adjacent region. Thus partial volumes of brain tissue, on the order of a few cubic micrometers in size, apparently have vastly different glucose supply in these stress conditions. The use of lumped constants in J Cereb Blood Flow Metab. Vol. 18, No. 1, 1998 estimating CMR g lucose with hexose analogs, assumes that brain glucose is uniformly distributed in intra-and ex tracellular spaces in the brain (Pardridge, 1983) , an as sumption that is in apparent conflict with the demonstra tion of CNS type A and type B capillary profiles. Be cause the evidence for regions of altered partial volumes of brain glucose has been observed in five different sei zure patients, it seems crucial to determine whether this also occurs in normal brain, or whether the appearance of type AB and type B endothelial profiles is restricted to pathophysiologic situations. It would also be important to know whether glucose transporter expression in the BBB endothelial cells is permanent, or whether cells are able to interconvert from type A to type B and back again, and if possible, the time frame of such a change. Glucose transporter regulation in the normal brain is be lieved to be posttranscriptional (Boado and Pardridge, 1993) , but in situ hybridization analyses of GLUTl mRNA signal are needed to confirm this in type A and type B endothelia.
Elevated Glutl transporter content type A endothelia might be speculatively associated in proximity to epilep togenic-prone neuron sets, which require capillaries with an ability to translocate increased glucose for the neurons to function through the course of a seizure. Because of the increased (diameter =1.3x) and cross-sectional area lumens of type A profiles, relatively greater perfusion of these capillaries can. be expected with the anticipated ictal increases in cerebral blood flow rates. (In a laminar FIG. 6. Electron microscopic identification of human serum albumin (HSA) epitopes are used here as an indicator of blood-brain barrier integrity in resected tissue. Note that in this capillary profile from the region of the resection judged from intraoperative EEG to be least actively spiking, the majority of the HSA epitopes are localized within the capillary lumen, with only a few epitopes in the capillary and neuropil. Scale bar = 0.5 jJm. flow situation, for example, the mass flow rate through tubes with a 1.3-fold difference in diameter would be increased by a factor of 2.9.) Conversely, the low-Glutl type B endothelia may be a mechanism for keeping non essential parenchymal cells hypometabolic, and by main taining this reduced activity, lessen the probability of interictal spiking activity turning into an ictal event.
The capillary glucose transporter variability may be analogous to capillary intermittence, which occurs in pe ripheral tissues, such as muscle, in which proportions of the capillaries are closed during periods of low activity, but open in response to strenuous exertion. Intermittent opening and closing of brain capillaries (capillary re cruitment) would be typically measured as changes in permeability-surface area; however, changes in perme ability-surface area are attributable to alterations in per meability, and experimental evidence supporting a selec tive change in surface area is not known for the brain (Pardridge, 1983) . It is interesting to speculate that the bimodal transporter distribution could be analogous; glu cose, the metabolic substrate, would be restricted instead of blood flow and oxygen supply. . Electron microscopic identification of HSA epitopes in a capillary profile taken from the more actively spiking region as indicated by intraoperative EEG analyses. Note that there is some extravasation of HSA into the neuropil. Also, there are HSA epitopes within the basal lamina, suggesting that extravasation of the albumin may be impeded (perhaps by a sievelike mechanism). Scale bar = 0.5 j..I m.
Differences in tissue samples based on EEG activity
Tissue samples from the more actively spiking regions of the resections exhibited proportionally more HSA ex travasation ( Fig. 9 ), indicating that BBB integrity was compromised to a greater degree in this region. Addi tionally, in the two patients studied, relatively more glio sis was demonstrated in this focal area (Fig. 10) , based on the observation of higher densities of GFAP epitopes in the more actively spiking regions of the resections, than in the less actively spiking areas.
As discussed above, capillary morphometric variables, such as luminal and abluminal membrane circumfer-ences and cytoplasmic areas, were increased in type A endothelia as compared with type B capillaries. A more subtle morphometric difference may characterize the cy toplasmic vacuolar areas, which were numerically (but not significantly) larger in more actively spiking areas. This is consistent with the work of Petito et al. (1977) , who demonstrated increased pinocytosis of peroxidase (after intravenous administration) in brain endothelia (in animal electrostimulation models) and suggested a cyclic AMP-mediated event. Furthermore, the increased pino cytosis was proportiopal to the duration and number of electro shocks (Petito et aI., 1976) . Kasantikul et al. FIG. 8 . Electron microscopic identification of HSA epitopes in a capillary profile from the more actively spiking region of the seizure resection. Note the extensive extravasation of HSA into the endothelial cell and pericyte-basal lamina, as well as the surrounding neuropil, suggesting that the barrier function is compromised in this region of the brain. Scale bar = 0.5 IJm.
(1983) have previously demonstrated thickening of the capillary basal lamina in temporal lobe epilepsy, con sisent with our observations (see Figs. 1-3) . Although significant differences in this measurement as a function of spiking activity were not seen, seizure-induced differ ences are assumed in the absence of measured pericyte basal lamina areas for normal human brain.
The quantity of endothelial cell cytoplasmic HSA seen in Fig. 8 is remarkable. A receptor for cationized albu min has been identified on BBB microvessels, and basic albumin (unlike native albumin) rapidly enters the cere brospinal fluid from blood (Kumagai et aI., 1987) . Au-toradiography using 125 I-labeled cationized albumin (Kumagai et aI., 1987) also suggests a similar distribu tion to that seen in Fig. 8 . The possibility that cationiza tion could contribute to the increases in capillary endo thelial cytoplasmic albumin (in capillaries from seizure resections) may be worthy of further study.
Comparison of Glut! in seizure resections and other CNS resections
We have previously examined Glutl transporter activ ity in resected material from hemangioblastoma (Corn ford et aI., 1995) and brain injury cases (Cornford et aI., , 1994] is not included in this comparison because of tis sue sampling differences; no attempt was made to exam ine all capillary profiles, or to locate any type AB or type B capillary profiles with reduced Glutl immunoreactiv ity .) In capillaries of the hemangioblastoma resections, we observed that 100% of the profiles were type A (Comford et a!., 1995), and in brain injury (Comford et aI., 1996) 88% of the profiles were type A and the re maining 12% were type AB. In seizure resections we observed a smaller proportion of entirely reactive type A capillary profiles (54% to 82%), with 18% to 46% of the profiles being type AB or type B (Fig. 4) .
REGION OF RESECTED TISSUE EXAMINED
It also appears that there may be fewer immunoreac tive Glutl epitopes in the profiles from seizure resections than observed previously in studies of brain injury and hemangioblastoma (Table 3 ) . In the entirely reactive type A capillaries, the total number of Glutl epitopes (1) per profile, (2) per unit length of luminal membrane, and (3) within the endothelial cytoplasm appears to be in creased 15% to 30% in hemangioblastoma and brain injury in comparison with seizure resections (Table 3) , but the sample sizes (in brain injury and hemangio blastoma) are not large enough to permit significance testing.
A mechanism by which glucose transporter activity is interictally regulated in the human epileptogenic focus is suggested by the present study. Some, but not all , of the brain capillary endothelial cells exhibit dramatically re duced Glut ! glucose transporter densities. The effect is seen on both luminal and abluminal endothelial cell membranes ; however, in these endothelial cells, the ab luminal membrane has proportionally greater Glutl den sity. (This latter observation may suggest that alterations in luminal membrane Glut l density are more dynamic than in the abluminal membrane.) The bimodal distribu tion of Glut ! transporter in endothelial cells may be a quantifiable indicator of regulatory activity. Interictal control of the transport of glucose within an epilepto genic focus, may be adjusted up or down by the propor tion of type A endothelial cells displaying abundant Glutl glucose transporter epitopes , as compared with the proportion of type B endothelia (in which the transporter density is markedly less).
Possible mechanisms of BBB Glutl modulation
Transporter recruitment in insulin-stimulated glucose transport (in fat, skeletal muscle, and heart) occurs through a redistribution of the Glut4 glucose transporter isoform from intracellular sites to the cell surface (Mueckler, 1990) . In other studies of upregulated Glut4 activity, glucose transporter proteins also relocated from cytoplasmic to the surface membranes in the anoxic heart (Wheeler, 1988) . Suggested possible mechanisms for the regulation of human BBB endothelial glucose transport (Cornford et aI. , 1994) include (1) redistribution of Glut l between membrane and cytoplasmic sites, or (2) alter ation in the total number of glucose transporter proteins. To evaluate these two possible alternatives , we examined the possibility that altered membrane density of endothe lial cell Glut ! transporters occurred concomitantly with an inverse change in cytoplasmic Glut l epitopes. Such analyses test the transporter recruitment (or cytoplasmic redistribution) hypothesis , and we could find no evidence for this phenomenon in human BBB endothelial cells. In both type A and type B capillaries , cytoplasmic Glut ! remained a remarkably constant fraction (2 1 % to 25 %) of the total Glut ! (Table 3) , and 75 % to 80% localized to the (luminal and abluminal) membranes. Modulation in BBB Glut ! thus appears to involve a mechanism whereby a change in the total number of immunoreactive Glutl epitopes is seen in the endothelial cell membranes.
Given the possible absence of an intracellular pool of Glut ! proteins available for recycling to capillary mem branes, alternative mechanisms can be considered. If the type A endothelial cells (with their larger lumens) are the major supply source of glucose during a seizure , the possibility exists that ictal upregulation of transporter activity may be accomplished in part by increased Glut ! carrier mobility ; i.e. , the intrinsic rate at which glucose is shuttled across BBB membranes increases, perhaps with-out an ictal increase in the number of membrane associated Glutl transporter proteins.
CONCLUSION
Until such time as the Glutl glucose transporter ac tivity is defined in normal human brain, the relationship of these two configurations of high-Glut ! endothelia and smaller low-Glut l endothelia to pathologic conditions will remain speCUlative. We conclude that these obser vations of surgically resected, seizure-damaged brain material (1) provide evidence for selective alteration of Glut I transporter activity in certain endothelial cells within and around the anatomical lesion ; (2) suggest that with the different sizes of type A and type B capillaries , blood flow and perfusion of adjacent small regions may vary significantly ; and (3) demonstrate the occurrence of a bimodal distribution of transporter (in which lO -fold alterations in Glut l transporter activity may be seen in type A versus type B endothelial cells). Our observation that discrete regions of brain parenchyma (on the order of cubic micrometers) can show marked changes in glu cose transporter activity implies that dramatically differ ent substrate concentrations and glucose utilization rates may also characterize these small regions. Clearly, fur ther examination of the biologic and physiologic signifi cance of the two configurations of endothelial cell glu cose transporter activity are needed , along with analyses of Glutl transporter regulatory mechanisms. We believe our study contributes important information about dis crete (microscopic and submicroscopic) changes that oc cur in the brain in response to insult ; the alterations in glucose transport imply functional metabolic changes, and effects on brain perfusion and CBF are suggested by microvasculature architectural changes , emphasizing the significance of BBB capillaries to brain homeostasis.
